Site access drives cost-effectiveness of TAVR, study finds

11/12/2012 | TCTMD.com

The cost-effectiveness of transcatheter aortic valve replacement in high-risk patients with severe aortic stenosis is access-site dependent, according to an analysis of the PARTNER trial published in the Journal of the American College of Cardiology. The findings support the transfemoral route, which demonstrated similar overall costs to surgery but shorter stays in the ICU and hospital overall and shorter procedural time.

View Full Article in:

TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ